SUMMARY The diagnostic value of exercise electrocardiography using 14 leads and thallium-201 scintigraphy were evaluated in 54 of 70 patients who underwent percutaneous transluminal coronary angioplasty (PTCA), both in the initial assessment and serial follow-up of patients after PTCA. Of the 45 patients who had successful PTCA, 36 had complete noninvasive studies performed before and 1 month after PTCA. Thirty-three of these 36 were asymptomatic 1 month after PTCA; the number of patients with an abnormal exercise ECG decreased from 20 to seven (p < 0.01) and with an abnormal thallium-201 scintigram from 21 to six (p < 0.001); the number of patients who had at least one of the two tests positive decreased from 26 to 10. The average treadmill time increased from 448 + 183 to 618 119 seconds (i < 0.001), and the average rate-pressure product increased from 19.81 ± 6.4 to 31.35 4.6 units x 10 (p < 0.001). Of the 10 patients with a positive test, two had a partial restenosis 50% but < 70% on the 6-month control angiogram; two had a residual stenosis ¢ 50% in a vessel that was not dilated and three had an abnormal scintigram before and 1 month after PTCA that subsequently became negative at 6 months. Six months after PTCA, a control angiogram was performed in 20 asymptomatic patients; 18 had an excellent PTCA result and two had a partial restenosis ¢ 50% but < 70%. The stress test results were normal in patients with a successful 6-month PTCA and abnormal in the two patients with a partial restenosis.
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Ten patients redeveloped angina within 3 months of PTCA; nine developed a restenosis ¢ 60% and one had a 90% left circumflex stenosis that could not be dilated or grafted. Six of the 10 patients had a normal exercise ECG and scintigram at 1 month that became abnormal when symptoms reappeared. The ratepressure product before PTCA and when angina symptoms recurred was similar (18.00 ± 2.20 vs 23.58 +
units x 103) (NS).
In conclusion, the use of clinical symptoms in conjunction with the physiologic data, ECG and myocardial scintigram acquired during exercise provide important short-term data on the angiographic evolution of PTCA results. The noninvasive tests may be useful in determining guidelines for repeat angiography in patients who have had PTCA.
PERCUTANEOUS transluminal coronary angioplasty (PTCA) is a new technique that may be useful in the treatment of 5-10% of patients with coronary artery disease who are suitable candidates for coronary artery bypass grafting. 1-3However, the method is still considered an investigational procedure and many issues are not resolved.)7 Most reported series of PTCA are small and follow-up is short because the technique requires considerable expertise, is relatively new, and suitable patient recruitment is limited in most hemodynamic laboratories. The role of noninvasive diagnostic tests in the selection and serial follow-up of patients who are considered for PTCA is not well defined. In some reports, stress test results and radionuclide studies are not discussed, and in others the sequential results of both tests are not described. The aim of this study is to evaluate exercise electrocardiography using 14 leads in conjunction with thallium-201 scintigraphy in a patient population referred for PTCA Between March 1980 and February 1981, 70 patients underwent a PTCA procedure at our hospital. Noninvasive tests were not performed in 14 patients because of unstable angina; two patients were excluded because the exercise ECG and thallium scintigrams were technically inadequate for study. The 54 remaining patients (42 men and 12 women) had a maximal stress test performed with rest and exercise thallium myocardial scintigraphy; the average age was 49 years (range 30-71 years). The baseline rest ECG was abnormal in 12 patients: three had a transmural myocardial infarction by Minnesota Code criteria and nine had ST-T-wave abnormalities. '9' 20 In 31 patients, f. blockers could not be progressively stopped before PTCA because of increased anginal symptoms (16 patients) or physician refusal (15 patients). None of the patients were taking digitalis in the 3-week interval before the tests or nitrates the day of the test. After PTCA, all tests were performed without medication. In asymptomatic patients, exercise was continued to at least 85% of the maximum age-predicted heart rate or 2 mm or more of horizontal or downsloping ST-segment depression. 20 In patients who re-EXERCISE ECG AND SCINTIGRAPHY TO EVALUATE PTCA/Scholl et al.
developed angina symptoms, the standard exercise end points were used 21' 22 Patient premedication was given before PTCA after the noninvasive tests were performed and consisted of sulfinpyrazone, 200 mg four times daily for 2 days, and diltiazem, 120 mg at bedtime and the morning of the procedure. During PTCA, an i.v. perfusion of nitroglycerin was maintained with supplementary boluses of intracoronary nitroglycerin when needed. Heparin, 10,000 units i.v., and rheomacrodex, 200 ml i.v., were administered at the onset of the procedure. All patients received sulfinpyrazone, 200 mg four times daily, for 6 months after PTCA. Beta blockers were progressively decreased and stopped in the 7-10 days after PTCA.
The exercise test was repeated at 1, 3 and 6 months after successful PTCA with thallium-201 scintigrams at 1 and 6 months. A control angiogram was routinely performed 6 months after PTCA in asymptomatic patients. The noninvasive tests were performed within 1 week of coronary angiography. In the patients who became symptomatic after the initially successful PTCA, coronary angiography and the sequence of noninvasive tests were repeated after 6 months ( fig. I ). Thallium scintigrams were acquired using standard techniques.27 One minute before exercise was terminated, 1.5-2.0 mCi of thallium-201 was injected i.v. and 5-10 minutes later, imaging was performed in the anterior, 30°and 600 left anterior oblique views using an Ohio nuclear series 550 mobile scintillation camera with a high-resolution, parallel-hole collimator. Images contained 300,000 counts over the heart using a 20% window and were stored on magnetic disc in a 128 x 128 matrix (V.I.P. 550). The images were processed in digital format with 1% background subtraction. Both the processed and analog images were photographed in black and white on 29 The thallium uptake of each segment was classified normal (0), mildly reduced (I) or severely reduced (2) by a consensus of observers. A scintigraphic score was obtained by summing the three views during exercise and reperfusion. In the patients with an abnormal reperfusion score, the difference between the exercise-reperfusion scintigrams determined the total scintigraphic score.
Cardiac Catheterization
Selective right and left coronary angiography was performed by the percutaneous technique using preformed polyethylene catheters as previously described.3" Each vessel was filmed in multiple views, including craniocaudal and caudocranial sagittal angulation views.3' Transluminal coronary angioplasty was performed using the technique described by GruntZig:. 32 Coronary stenoses were expressed as the percent luminal narrowing compared with the nearest normal arterial segment in the view that appeared the most severe.33 The angiograms were reviewed by the same three angiographers simultaneously before and after PTCA. An increase in 20% of the luminal diameter or a decrease of 50% in the mean transstenotic arterial pressure gradient determined a successful result. Of the 54 patients who had a PTCA attempt performed and who had noninvasive tests before PTCA 45 had one, seven had two-and two had three-vessel disease; 41 patients had LAD stenosis. Intercoronary collateral vascularization was present in four patients before PTCA and was not visible immediately after the procedure. The left ventricular contraction pattern evaluated in the 30°right anterior oblique position was normal in 46 patients.
Analysis of Results
The 36 patients who had a maximal stress test and scintigraphy before and after PTCA were compared. Nonparametric differences were examined using a chisquare test. Parametric differences were examined using the t test and analysis of variance. The left ventricular contraction pattern was unchanged from that on the left ventriculogram before PTCA except in patient 32, who had a silent infarct 3 months after PTCA and the new appearance of segmental akinesis. The exercise ECG and scintigram normalized 1 month after successful PTCA in this patient but became abnormal after infarction (table 2) .
Results
In seven of the 10 patients who developed a restenosis, a second PTCA was attempted. Among the six patients who had a successful second PTCA, all were asymptomatic an average of 5 months later; all had a normal exercise ECG and thallium scintigrams at 1 month ( fig.  5 ). The exercise ECG became abnormal at 3 months and 6 months, respectively, in two patients (nos. 12 and 30) who underwent 6-month control angiography. Both had a normal myocardial scintigram but had restenosed to 60%; two other patients who had a control angiogram at 6 months and a normal exercise ECG and myocardial scintigram had a successful second PTCA. Discussion
Exercise electrocardiography and radionuclide studies provide valuable objective data in the initial assessment and serial follow-up of patients with coronary artery disease. 22-25 27337 Percutaneous transluminal coronary angioplasty is a new therapeutic advance that directly affects the angiographic evolution of patients with ob- Abbreviations: PTCA = percutaneous transluminal coronary angioplasty; RCA right coronary artery: LAD = left anterior descending coronary artery; Cx = left circumflex coronary artery: CABG = coronary artery bypass grafting: MI = myocardial infarction, structive coronary disease and which may influence their subsequent clinical course. The initial success of PTCA is determined at cardiac catheterization. Serial changes in the dilated and nondilated arteries may be detected by changes in the patient's clinical status or by noninvasive diagnostic tests or by repeat coronary angiography. The aim of the present study was to evaluate the role of exercise electrocardiography and thallium-201 scintigraphy in the initial assessment of patients for PTCA, and to determine if restenosis of the dilated artery or progression of disease can be predicted.
Initial Assessment before PTCA The sensitivity of exercise electrocardiography and thallium scintigraphy was 0.59 and 0.67; it was 0.78 and 0.80, respectively, if patients with a submaximal stress were excluded. The values are within the range of 0.50-0.81 for the exercise ECG and 0.56-0.80 for thallium scintigraphy reported for patients who have one-vessel coronary disease.38 Thirteen of 20 patients (65%) had an abnormal exercise ECG before PTCA in the study of Hirzel et al.'5 and 19 of 22 (86%) had an abnormal exercise ECG in the series reported by Cowley et al. 18 The sensitivity of thallium scintigraphy was 88% and 80% in these two studies, respectively.
The sensitivity of exercise electrocardiography and thallium scintigraphy in a population referred for PTCA is influenced by the selection criteria. If only patients who have objective evidence of myocardial ischemia as determined by exercise electrocardiography and scintigraphy are selected, the sensitivity of both diagnostic tests will be proportionately greater. Variables such as the exercise ECG lead system21 22' 2426 and the accumulation, display and subsequent analysis of scintigraphic images27 also determine test sensitivity and may explain, in part, some of the interstudy differences.
Patients referred for PTCA are highly selected; many have one-vessel coronary disease, predominantly of the left anterior descending coronary artery. The patients who are selected usually require a stenosis that is proximal, concentric, not heavily calcified, and that does not include a major secondary branch. Our data confirm that the sensitivity of exercise electrocardiography and thallium scintigraphy in a population of patients referred for PTCA is similar to results obtained in a larger and more heterogeneous population of patients with a similar extent of coronary disease."
An analysis of the exercise ECG, physiologic results and the scintigraphic data are indicated in the workup of patients before PTCA. The scintigram, when abnormal, is more precise than the exercise ECG in determining the area of myocardial ischemia, which is particularly useful in assessing restenosis in the dilated artery.
Serial Follow-up The initial success rate of PTCA was 64% in our series of 70 patients, similar to the 60-65% reported by 386 CIRCULATION EXERCISE ECG AND SCINTIGRAPHY TO EVALUATE PTCA/Scholl et al. others.". 7. 10 The rate of restenosis in the first 6 months was 31% in the 39 patients who had a successful PTCA and repeat coronary angiography, slightly greater than the 19-23% reported in other series.', 10 The incidence of restenosis may have been increased by attempting PTCA in patients with fixed coronary lesions and variant angina.39 When the patients with variant angina were excluded, the rate of restenosis in the first 6 months in our series was 23% (seven of 30 patients). Progression of coronary disease in nondilated arteries did not occur in the 6-month interval after PTCA in this series. In two studies in which the natural history of coronary disease was determined by control angiography 12 and 18 months after randomization to medical therapy, the rate of disease progression was 21% and 29%, respectively.37 40 In the former study, disease progression was defined as a new stenosis B 70% or total occlusion of a previous stenosis. In the latter study, four angiographic criteria were used. Disease progression was more frequent in the patients who had more extensive coronary disease. 40 The data suggest that in the first 6-12 months after PTCA, persistence or development of an abnormal noninvasive test result is more likely to be the result of restenosis than evolution of coronary disease in nondilated arteries.
In most other reports on PTCA, noninvasive test results are not analyzed after the patients are subdivided into symptomatic and asymptomatic groups.8 [15] [16] [17] [18] Clinical symptoms are very important in evaluating serial changes in the angiographic status of the patient, especially when evaluating the diagnostic usefulness of noninvasive test results.22 41 42 In our symptomatic patients, serial comparison of the noninvasive test results provided objective evidence of restenosis in 89% of the patients (eight of nine). The ninth patient had a 95% right coronary stenosis, large intercoronary collaterals, and a normal exercise ECG and thallium scintigram. In the asymptomatic patients, the noninvasive test results permitted us to diagnose restenosis or residual disease in 20% of the patients (four of 20) who had control angiography, and in two of five patients after a second PTCA attempt. The use of treadmill work time and rate-pressure product in the serial evaluation of patients before and after PTCA was useful in distinguishing false-positive from true-positive results. Training effects, pharmacologic interventions and the exercise conditions and protocol must be considered before attributing differences in the latter two variables to changes in coronary anatomy.
In our series, 64% of abnormal thallium scintigrams (14 of 22) returned to normal 1 month after successful PTCA, compared with 100% in the series of Hirzel et al. '6 Since the restenosis rate in both series were similar, the difference may be a function of the exercise protocol used, which was maximal at 1 month in our series and only submaximal in the study of Clinical Implications PTCA is considered an investigational procedure; thus, a control coronary angiogram would seem warranted after PTCA in asymptomatic patients until a larger clinical experience has accumulated. However, if our results are confirmed in a larger data pool, guidelines for repeat coronary angiography might be determined over the short term by the patient's symptomatic status and the results of the exercise ECG and myocardial scintigram. Since noninvasive test results between 1 and 3 months are similar in asymptomatic patients and since restenosis, when it occurs, usually happens in the first 3 months, the exercise ECG and myocardial scintigram in asymptomatic patients could be performed at 3 months rather than sequentially at 1, 3 and 6 months. Asymptomatic patients who have an abnormal test after PTCA at a rate-pressure product similar to that before PTCA should be followed closely because restenosis is likely. In symptomatic patients, the noninvasive tests provide objective evidence of myocardial ischemia and help characterize symptoms. They also provide a baseline document for subsequent management and evaluation of treatment if a second PTCA attempt or subsequent bypass graft surgery is performed.
